Arrowhead Research, the parent firm of Calando Pharmaceuticals, said that Douglass Given has joined its board of directors.
Given is currently chairman and CEO of Vivaldi Biosciences, chairman of Via Pharmaceuticals, and an investment partner at Bay City Capital.
Alnylam Pharmaceuticals has appointed Marsha Fanucci to its board of directors.
Fanucci is the former CFO of Millennium Pharmaceuticals, and currently sits on the board of Ironwood Pharmaceuticals and Momenta Pharmaceuticals.
She previously served as vice president of corporate development and strategy at Genzyme.